General Mills: The Pantry and the Pet Store

In September 2024, a mother of three in suburban Minneapolis who had been buying Annie's Shells & Cheddar every week for five years opened a box and noticed the sauce tasted different. Thinner. Less sharp. She checked the ingredients and found that butter and nonfat milk — the fourth and fifth ingredients since the product's founding — had been replaced by cornstarch. The package still said "Now Cheesier."

She was not the first to notice. Mouse Print, the consumer watchdog site, had already documented it: 22.3% less protein. 22.3% less calcium. Cheaper ingredients, same price, new marketing language.

Two months later, a Goldendoodle named Maya in Lake Forest, Illinois, died from dilated cardiomyopathy. Her owners, Ryan and Diana Walsh, had been feeding her Blue Buffalo Wilderness grain-free food for years. They filed a class action in the Northern District of Illinois alleging that General Mills concealed known links between its grain-free formulas and DCM. The FDA's investigation into grain-free pet food and DCM, opened in 2018, remains active eight years later. Blue Buffalo Wilderness has 31 reported DCM cases in the FDA database — more than 7% of all brand-specific cases.

Three months after that, on March 18, 2026, General Mills reported quarterly earnings of $0.64 per share against a $0.73 estimate. The stock fell to near its lowest level since 2010. Wells Fargo downgraded it to Underweight.

I am telling you about all three events because they describe the same company from three different angles, and the stock at $33.69 is pricing in only one of them.

Investment Council: $GIS →

All current verdicts: The Verdict Board →

General Mills reached $67 in December 2024. It was the culmination of a decade-long trade: buy the boring dividend aristocrat, collect 3%, let Holistic Margin Management grind out 50 basis points of cost savings every year, and reinvest in brands that have sat on American kitchen shelves since the Eisenhower administration. Cheerios. Pillsbury. Betty Crocker. The kinds of brands that don't go viral and don't need to.

Then three things happened in sequence.

First, volume fell off a cliff. North America Retail, which accounts for 63% of General Mills' revenue, has now declined for eight consecutive quarters. The culprit is not one thing — it's everything at once. Private label unit share reached 23.9% by end of 2025, up from 22.1% in 2021. Aldi traffic grew 8% year over year. The massive middle market, as management itself conceded on the Q2 FY2026 call, is "trading down aggressively." GLP-1 drugs, now prescribed to users in roughly 20% of U.S. households, are reducing snacking and cereal consumption in ways the company has no moat against.

Second, the pricing lever broke. During 2022 and 2023, General Mills — like every packaged food company — pushed through double-digit price increases. It worked. Margins expanded. The stock hit $67. But consumers hit back. The Honey Nut Cheerios mega box shrank from 29.4 ounces to 27.2 ounces. Family-size cereals dropped from 19.3 to 18.1 ounces. A class action was filed in December 2025 alleging that Fruity Cheerios boxes are more than half empty air. And in April 2025, People's Union USA organized a week-long boycott of General Mills, calling the company's products "ultra-processed garbage." General Mills did not publicly respond.

Third, the crown jewel got scratched. General Mills paid $8 billion for Blue Buffalo in 2018, the largest packaged-food acquisition of the decade, betting that premium pet food would be the growth engine the pantry business no longer was. Pet food revenue has indeed grown — up 4% in FY2025 — but the brand now faces an active DCM class action, an eight-year FDA investigation, veterinary professionals who "hesitate to recommend" it, and a ConsumerAffairs page with 2,041 reviews that reads like a catalog of pet owner nightmares.

Those three forces — volume erosion, pricing exhaustion, and pet-segment reputation damage — brought the stock from $67 to $33.69 in eighteen months.

The trajectory is unambiguous. Revenue has declined for two consecutive fiscal years. Adjusted EPS has fallen from $4.52 to an estimated ~$3.45 in FY2026 — a 24% decline in two years. Operating margins, which peaked above 20% in FY2024, have been cut nearly in half in some quarters (Q3 FY2026 came in at 12.4% on a GAAP basis). Net debt to EBITDA has climbed to 3.8x, approaching the 4.0x threshold that S&P considers the floor for BBB investment-grade.

The 7% dividend yield tells you this is not a stable-income story anymore. It is a distress signal. The payout ratio stands at 53-59%, and FCF coverage dipped below 1.0x in one recent quarter. General Mills has paid dividends for 127 consecutive years. The question is whether it can continue without cutting.

This is the central divergence. On Chewy and DogFoodAdvisor — curated, professional review platforms — Blue Buffalo scores 4.5 to 4.6 out of 5 stars, with 85% of reviewers rating the product positively. On PissedConsumer, ConsumerAffairs, and ComplaintsBoard — platforms where customers go when something has gone wrong — the negative rate ranges from 60% to 90%.

We tested whether this gap is statistically significant using a two-proportion Z-test.

Professional platforms: 50 of 500 reviews negative (10.0%)
Consumer complaint platforms: 1,550 of 2,490 reviews negative (62.2%)

Z = -21.38. p < 0.0001.

The difference in negative-review rates is 52.2 percentage points (95% CI: 49.0% to 55.5%). This is not a sampling artifact. It is one of the largest review-platform divergences we have documented in this series.

The interpretation is not that complaint platforms are biased (they are, by design). The interpretation is that General Mills has a large and growing population of customers who are actively unhappy with the products, and the company's aggregate brand score hides that population because they don't leave reviews on Chewy.

We ran a Mann-Kendall trend test on General Mills' adjusted operating margin across 11 quarters (FY2024 Q1 through FY2026 Q3).

S = -43. Z = -3.27. p = 0.001.

The trend is statistically significant at the 1% level. Sen's slope is -0.60 percentage points per quarter, meaning that at the current trajectory, operating margins are compressing by roughly 2.4 percentage points per year. The margin has dropped from 20.8% at its peak (FY2024 Q2) to 12.4% (FY2026 Q3 GAAP). If the trend continues unbroken, General Mills' operating margin crosses into single digits by FY2027 Q3.

Management expects sequential improvement in Q4 FY2026 due to a 53rd-week tailwind, favorable timing, and claimed market-share momentum. Whether that inflection is real or temporary will be clear on July 1, 2026, when the company reports Q4 and provides FY2027 guidance.

The financials capture the volume decline and the margin compression. They do not capture the qualitative damage to the brand portfolio.

General Mills is fighting a war on six fronts simultaneously, and none of them show up in the P&L yet:

The shrinkflation backlash. Beyond the documented size reductions in Cheerios and the Fruity Cheerios slack-fill lawsuit, General Mills reformulated Annie's mac and cheese by removing butter and nonfat milk and adding cornstarch — a change Consumer Reports called "skimpflation." The company marketed the reformulated product as "Now Cheesier." The consumers who discovered the swap did not use that word.

The Blue Buffalo DCM overhang. The Walsh v. Blue Buffalo class action is active in the Northern District of Illinois. The FDA DCM investigation has been open since 2018. Thirty-one cases of dilated cardiomyopathy have been specifically linked to Blue Buffalo Wilderness in FDA reporting. Blue Buffalo does not satisfy WSAVA nutritional guidelines — the standard that Purina, Hill's, Royal Canin, and Iams meet. The veterinary community is increasingly reluctant to recommend the brand. If the class action survives the motion to dismiss, or if FDA issues formal findings, the $8 billion acquisition could become a write-down story.

The food-safety pattern. Pillsbury Pizza Pops were recalled for E. coli in December 2025, expanded in January 2026, with 8 hospitalizations. Gold Medal Flour was recalled for Salmonella across 413,862 bags over a 2.5-year period ending September 2025. Lucky Charms generated 558 FDA illness reports in 2022 and roughly 3,000 reports on iwaspoisoned.com. No single recall is existential, but the pattern — across three different product lines, three different contaminants, across three consecutive years — suggests systemic quality-control pressure at a company that is simultaneously cutting costs and closing plants.

The GLP-1 structural shift. GLP-1 users reduce caloric intake by approximately 30%. Roughly 20% of U.S. households now include at least one GLP-1 user. Analysts project that GLP-1 households will account for more than a third of food and beverage spending within five years. General Mills' core portfolio — cereal, snacks, baking mixes — sits directly in the crosshairs. The company's response so far: Honey Nut Cheerios Protein and smaller pack sizes. That is not a moat. It is a levee.

The innovation retreat. General Mills closed G-Works, its internal innovation hub, in March 2025, after six years of operation. It halted all new investments through 301 Inc., its venture capital arm. Both closures together eliminated roughly 40 positions and the company's primary mechanisms for discovering the next growth category. The new "Strategic Growth Office" that replaces them has not yet announced any initiatives.

The employee anxiety. Glassdoor overall: 4.0 out of 5, down 2% year over year. Indeed management rating: 3.3 out of 5. Employees on anonymous forums describe a cycle of restructuring every three to four years, with standardized career structures being replaced by competitive comparative assessments. Three Missouri manufacturing plants are closing by mid-2026 — 163 jobs in St. Charles alone. The company has not disclosed total headcount reductions from the $130 million restructuring.

Recovering:

NOT recovering:

Unknown — resolves July 1, 2026 (Q4 FY2026 earnings):

1. Reddit and Twitter/X data is indirect. Both platforms block direct crawling; our sample of ~35 data points per platform is sourced from indexed references and media reports citing those platforms. Direct API access would yield significantly larger samples. The negative-sentiment skew we observe is consistent across all accessible channels, but the social-media signal is weaker than in tickers with crawlable platforms.

2. Professional review scores for Blue Buffalo remain high. Chewy (4.6/5) and DogFoodAdvisor (4.5/5) tell a different story than ConsumerAffairs (skewing negative across 2,041 reviews). The divergence is real and statistically significant, but it means the brand's aggregate positioning is stronger than the complaint data alone would suggest.

3. The 7% dividend yield has not been cut. Management recently approved a small increase. The payout ratio (53-59%) and FCF coverage (1.62x full-year, but dipping below 1.0x in one quarter) leave room for continuation, especially if FY2027 earnings stabilize. A dividend cut is a risk, not a certainty.

4. General Mills has 95% domestic sourcing. Unlike many packaged-food peers, it is relatively insulated from tariff escalation. The 1-2% COGS tariff impact is manageable and partially offset by product reformulation.

5. The stock is at trough valuations. At 8.7x trailing P/E, General Mills trades cheaper than every major packaged-food peer except the deeply distressed Conagra. The sector median forward P/E is ~14.3x, meaning GIS trades at a ~24% discount. If any of the bear-case fears prove overdone, the re-rating upside is significant.

General Mills at $33.69 is a turnaround bet on a 127-year-old company that has temporarily lost its pricing power, is fighting a multi-front consumer backlash, and is restructuring while its largest segment declines. The bull case and bear case are almost perfectly balanced:

Expected value at current prices: ~$38, or +13% upside plus 7% yield = ~20% total return.

The math looks favorable, but the distribution is wide. A 30% chance of losing 17-35% is not trivial. The dividend, which looks like protection, could become the catalyst for the next leg down if it's cut.

Now: General Mills is a WAIT at $33.69. The valuation is objectively cheap at 8.7x trailing earnings, cheaper than every viable peer. The 7% dividend yield provides income while you wait. But the operating margin trend is statistically significant, the consumer sentiment data shows a brand portfolio under active stress, and the single most important data point — FY2027 guidance — does not exist yet.

Next catalyst: July 1, 2026 — Q4 FY2026 earnings + FY2027 guidance. This is the report that matters. The 53rd-week tailwind in Q4 will make the headline numbers look better than the underlying trend. The real tell is FY2027 guidance: does management guide to organic growth (even 1%), or another year of decline?

Decider date: July 1, 2026. If FY2027 guidance shows organic revenue growth and operating margin stabilization above 16%, the re-rating begins and the stock is a buy in the $30-35 range. If guidance is flat-to-negative with margins continuing to compress, the dividend comes under pressure, the BBB rating is at risk, and the stock is a sell despite the cheap headline multiple.

On July 1, 2026, General Mills reports Q4 FY2026 and provides FY2027 guidance. This is where the pantry-versus-pet-store question gets answered.

We will publish a follow-up analysis within 48 hours of the print, covering: FY2027 organic revenue guidance (the single most important number), operating margin trajectory (does the Mann-Kendall slope flatten or accelerate), North America Retail volume trend (the eighth consecutive quarter of decline or the first inflection), any dividend or capital allocation commentary, and the first full quarter under new COO Dana McNabb's operational leadership.

Subscribers get the update as it publishes. The catalyst is dated. The question is binary. Everything before July 1 is noise.

Investment Council: $GIS →

All current verdicts: The Verdict Board →